
Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)
Author(s) -
Mehra Golshan,
Constance Cirrincione,
William M. Sikov,
Lisa A. Carey,
Donald A. Berry,
Beth Overmoyer,
N. Lynn Henry,
George Somlo,
Elisa Port,
Harold J. Burstein,
Clifford A. Hudis,
Eric P. Winer,
David W. Ollila,
for the Alliance for Clinical Trials in Oncology
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/3qn5-sn85
Subject(s) - medicine , breast cancer , stage (stratigraphy) , oncology , neoadjuvant therapy , cancer , paleontology , biology